{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:34:06Z","timestamp":1791380046398,"version":"4.3.3"},"reference-count":10,"publisher":"MedWorks Media","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacol Bull"],"abstract":"<jats:p>Objectives\nA pilot of clinical services provided by psychiatric clinical pharmacists in an outpatient clinic are described and evaluated. The primary objective was to evaluate the difference in change of Patient Health Questionnaire (PHQ)-9 and\/or Generalized Anxiety Disorder (GAD) Questionnaire scores between the two groups. Secondary objectives were to assess time patients spent in clinic, time to target psychotropic medication dose, and patient self-reported medication adherence.\nExperimental Design\nData were collected from January 2014 to November 2015 for patients with depression and\/or anxiety who had an appointment within an outpatient psychiatric clinic with either a provider (control) or both a provider and clinical pharmacist (case).\nPrinciple Observations\nA total of 217 patients were included in the study; 117 patients served as controls and 100 patients received clinical pharmacist intervention. No statistical difference was detected in the primary outcome. However, patients in the case group had higher baseline PHQ-9\/GAD scores, and the frequency of measured values was lower than anticipated, limiting power to detect a difference. All secondary outcomes achieved statistical significance. Both time in clinic and time to reach a stabilized psychotropic medication regimen were shorter in the control group. Patient self-reported adherence favored a higher adherence rate in the intervention group.\nConclusion\nWhile this study found no significant difference in the change in PHQ-9\/GAD scores between groups, it demonstrated the need for enhanced utilization of measurement-based outcomes in the psychiatric setting. Pharmacists provide a range of services to patients and providers and can serve as key partners to enhance measurement-based care.<\/jats:p>","DOI":"10.64719\/pb.4562","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T11:39:16Z","timestamp":1761046756000},"page":"18-28","source":"Crossref","is-referenced-by-count":2,"title":["A Pilot Evaluating Clinical Pharmacy Services in an Ambulatory Psychiatry Setting"],"prefix":"10.64719","volume":"48","author":[{"given":"Valerie A.","family":"Lindell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole L.","family":"Stencel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel C.","family":"Ives","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen M.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Fluent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hae Mi","family":"Choe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolene R.","family":"Bostwick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54175","published-online":{"date-parts":[[2025,8,12]]},"reference":[{"key":"ref1","unstructured":"CDC [online database] Mental Health. Atlanta, GA. (accessed 2015 August). Retrieved from http:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/mm5434a1.htm."},{"key":"ref2","unstructured":"CDC [online database] CDC promotes public health approach to address depression among older adults. Atlanta, GA. (accessed 2015 August). Retrieved from http:\/\/www.cdc.gov\/aging\/publications\/briefs.htm."},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Goldstone LW, DiPaula BA, Caballero J, Park SH, Price C, Slater MZ. Improving medication-related outcomes for patients with psychiatric and neurologic disorders: value of pharmacists as part of the health care team. Ment Health Clin. 2015;5(1):1\u201328.","DOI":"10.9740\/mhc.2015.01.001"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Adler DA, Bungay KM, Wilson IB et al. The impact of a pharmacist intervention on 6-month outcomes in depressed primary care patients. Gen Hosp Psychiatry. 2004;26:199\u2013209.","DOI":"10.1016\/j.genhosppsych.2003.08.005"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Bungay KM, Adler DA, Rogers WH et al. Description of a clinical pharmacist intervention administered to primary care patients with depression. Gen Hosp Psychiatry. 2004;26:210\u2013218.","DOI":"10.1016\/j.genhosppsych.2004.01.004"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Finley PR, Rens HR, Pont JT, Gess SL, Louie C, Bull SA et al. Impact of a collaborative care model on depression in a primary care setting: a randomized controlled trial. Pharmacotherapy. 2003;23(9):1175\u20131185.","DOI":"10.1592\/phco.23.10.1175.32760"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Finley PR, Crismon ML, Rush AJ. Evaluating the impact of pharmacists in mental health: a systematic review. Pharmacotherapy. 2003;2015;235(12)(1):1634\u20131644. 1\u201328.","DOI":"10.1592\/phco.23.15.1634.31952"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Ali S, Getz MJ, Chung H. Bridging the gap for patients with mental illness. Ment Health Clin. 2015;5(1):40\u201345.","DOI":"10.9740\/mhc.2015.01.040"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Johnson JA, Sayah FA, Wozniak L, Rees S, Soprovich A, Qiu W et al. Collaborative care versus screening and follow-up for patients with diabetes and depressive symptoms: results of a primary care-based comparative effectiveness trial. Diabetes Care. 2014;37(12):3220\u20133226.","DOI":"10.2337\/dc14-1308"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Kooij M, Heerdink E, van Dijk L, van Geffen E, Belitser S, Bouvy M. Effects of telephone counseling intervention by pharmacists (TelCIP) on medication adherence; results of a cluster randomized trial. Front Pharmacol. 2016;7:269.","DOI":"10.3389\/fphar.2016.00269"}],"container-title":["Psychopharmacology Bulletin"],"original-title":[],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:34:20Z","timestamp":1791315260000},"score":1,"resource":{"primary":{"URL":"https:\/\/medworksmedia.com\/pb-article\/a-pilot-evaluating-clinical-pharmacy-services-in-an-ambulatory-psychiatry-setting\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,12]]},"references-count":10,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,8,12]]}},"URL":"https:\/\/doi.org\/10.64719\/pb.4562","relation":{},"ISSN":["2472-2448"],"issn-type":[{"value":"2472-2448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,12]]}}}